Pharmacotherapy of attention deficit/hyperactivity disorder in individuals with autism spectrum disorder: A systematic review of the literature.
Gagan JoshiTimothy WilensElizabeth S FirminBarbora HoskovaJoseph BiedermanPublished in: Journal of psychopharmacology (Oxford, England) (2020)
here is a scarcity of controlled trials examining ADHD treatments in ASD populations, particularly in intellectually capable individuals with ASD and in adults. Response to ADHD medications in ASD were adversely moderated by the presence of intellectual disability and mood lability.